Blue Cross and Blue Shield of Minnesota launches Omada’s type 2 diabetes management program
Omada has published 11 peer-reviewed studies and is currently running the largest-ever randomized controlled trial of a digital…
14 Nov 19
Omada has published 11 peer-reviewed studies and is currently running the largest-ever randomized controlled trial of a digital…
28 Oct 19
Fiasp is an ultra fast-acting insulin that enters bloodstream two times faster than Novo Nordisk’s NovoLog
23 Oct 19
Type 2 diabetes is the fastest growing chronic disease in Australia, and Aboriginal and Torre Strait Islander Australians…
16 Oct 19
Abbott and Tandem will sign a final agreement for the technical implementation of device integration and associated commercial…
15 Oct 19
Omada Health to offer integrated solution to employers and health plans for eligible Type 2 diabetes patients
10 Oct 19
Three recent clinical publications demonstrate that Cellvizio AQ-Flex 19 Confocal Miniprobe significantly improves diagnostic accuracy versus standard of…
24 Sep 19
ALRT’s comprehensive diabetes management system now provides decision support for healthcare providers treating non-insulin dependent type 2 diabetes…
24 Sep 19
The FDA clearance indicates that the pump is capable of communicating securely with compatible, digitally connected devices
19 Sep 19
The SmartGuard Auto Mode feature in the MiniMed 670G system automates and personalizes the delivery of basal insulin…
17 Sep 19
Medtronic and Novo Nordisk partnership is aimed at developing solutions for dosing data from Novo Nordisk’s Smart Insulin…